{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:44:52Z","timestamp":1777898692645,"version":"3.51.4"},"reference-count":17,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>During 2014-2019, the Utah Department of Health (UDOH) enhanced its surveillance program for acute hepatitis C virus (HCV) infections by mandating electronic reporting of negative HCV test results in 2015 and liver function test results in 2016. UDOH also engaged with blood and plasma donation centers beginning in 2014 and syringe exchange programs in 2018 to encourage manual reporting of negative HCV test results from facilities without electronic reporting capabilities. UDOH hepatitis surveillance staff also provided training for case investigations in 2017. The number of cases detected increased 14-fold, from 9 during 2012 to 127 during 2019. In 2019, of 127 cases, 55% (n = 70) were detected through negative HCV test results reported electronically before positive test results (ie, recent seroconversions), 25% (n = 32) through positive HCV test results and elevated liver function test results, 18% (n = 23) through manually reported negative HCV test results, and 2% (n = 2) through positive HCV test results and clinical evidence. Challenges to surveillance included accessing patients for investigations and engaging donation centers in reporting negative test results. Utah\u2019s experience demonstrates practical considerations for improving surveillance of acute HCV infections.<\/jats:p>","DOI":"10.1177\/00333549221101381","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T02:15:36Z","timestamp":1654827336000},"page":"410-415","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhancing Surveillance Protocols for Acute Hepatitis C Virus Infection, Utah, 2014-2019"],"prefix":"10.1177","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7088-9640","authenticated-orcid":false,"given":"Nathaniel M.","family":"Lewis","sequence":"first","affiliation":[{"name":"Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, GA, USA"},{"name":"Utah Department of Health, Salt Lake City, UT, USA"},{"name":"Now with Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Eason","sequence":"additional","affiliation":[{"name":"Utah Department of Health, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bree","family":"Barbeau","sequence":"additional","affiliation":[{"name":"Utah Department of Health, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Boulton","sequence":"additional","affiliation":[{"name":"Utah Department of Health, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyn K.","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Utah Department of Health, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela C.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Utah Department of Health, Salt Lake City, UT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"bibr1-00333549221101381","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2939"},{"key":"bibr2-00333549221101381","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268812001033"},{"key":"bibr3-00333549221101381","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis: hepatitis C questions and answers for health professionals. 2020. Accessed May 21, 2021. https:\/\/www.cdc.gov\/hepatitis\/hcv\/hcvfaq.htm#section2"},{"key":"bibr4-00333549221101381","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis: overview and statistics. 2020. Accessed May 21, 2021. https:\/\/www.cdc.gov\/hepatitis\/hcv\/hcvfaq.htm#section1"},{"key":"bibr5-00333549221101381","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis: testing recommendations for hepatitis C virus infection. 2020. Accessed May 21, 2021. https:\/\/www.cdc.gov\/hepatitis\/hcv\/guidelinesc.htm"},{"key":"bibr6-00333549221101381","unstructured":"Miller J. Former Utah nurse pleads guilty to stealing painkillers and infecting seven patients with hepatitis C. The Salt Lake Tribune. September 25, 2019. Accessed May 21, 2020. https:\/\/www.sltrib.com\/news\/2019\/09\/25\/former-utah-nurse-pleads"},{"key":"bibr7-00333549221101381","unstructured":"Council of State and Territorial Epidemiologists. Public health reporting and national notification for acute hepatitis C. 2012. Accessed May 21, 2021. https:\/\/cdn.ymaws.com\/www.cste.org\/resource\/resmgr\/PS\/11-ID-05.pdf"},{"key":"bibr8-00333549221101381","unstructured":"Council of State and Territorial Epidemiologists. Revision of the case definition of hepatitis C for national notification. 2016. Accessed May 21, 2021. https:\/\/cdn.ymaws.com\/www.cste.org\/resource\/resmgr\/2015PS\/2015PSFinal\/15-ID-03.pdf"},{"key":"bibr9-00333549221101381","unstructured":"Centers for Disease Control and Prevention. Strengthening surveillance in jurisdictions with high incidence of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections (CDC-RFA-PS17-1703). Accessed May 21, 2020. https:\/\/www.federalgrants.com\/Strengthening-Surveillance-in-Jurisdictions-with-High-Incidence-of-Hepatitis-C-Virus-HCV-and-Hepatitis-B-Virus-HBV-Infections-62715.html"},{"key":"bibr10-00333549221101381","unstructured":"Utah Department of Health, Bureau of Epidemiology. Utah\u2014National Electronic Disease Surveillance System (UT-NEDSS). Accessed May 21, 2020. https:\/\/epi.health.utah.gov\/utah-national-electronic-disease-surveillance-system-ut-nedss"},{"key":"bibr11-00333549221101381","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis surveillance\u2014United States. Accessed May 21, 2020. https:\/\/www.cdc.gov\/hepatitis\/statistics\/SurveillanceRpts.htm"},{"key":"bibr12-00333549221101381","unstructured":"Council of State and Territorial Epidemiologists. Revision of the case definition for hepatitis C. 2019. Accessed March 29, 2022. https:\/\/cdn.ymaws.com\/www.cste.org\/resource\/resmgr\/2019ps\/final\/19-ID-06_HepatitisC_final_7.pdf"},{"key":"bibr13-00333549221101381","doi-asserted-by":"publisher","DOI":"10.1177\/003335491112600105"},{"key":"bibr14-00333549221101381","doi-asserted-by":"publisher","DOI":"10.1177\/003335491312800610"},{"key":"bibr15-00333549221101381","unstructured":"US Department of Health and Human Services. Viral Hepatitis National Strategic Plan: A Roadmap to Elimination for the United States, 2021-2025. Published 2020. Accessed May 21, 2021. https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf"},{"key":"bibr16-00333549221101381","unstructured":"Centers for Disease Control and Prevention. Division of Viral Hepatitis: 2025 Strategic Plan. Published 2020. Accessed May 21, 2021. https:\/\/www.cdc.gov\/hepatitis\/pdfs\/DVH-StrategicPlan2020-2025.pdf"},{"key":"bibr17-00333549221101381","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102755"}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549221101381","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00333549221101381","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549221101381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:38:14Z","timestamp":1777628294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00333549221101381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1177\/00333549221101381"],"URL":"https:\/\/doi.org\/10.1177\/00333549221101381","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]}}}